[
    [
        {
            "time": "2023-05-07",
            "original_text": "健帆生物：占总股本0.3429%限售股将于5月7日上市流通 解禁",
            "features": {
                "keywords": [
                    "健帆生物",
                    "限售股",
                    "上市流通",
                    "解禁"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative",
                "event_type": "stock_release",
                "proportion_of_shares": "0.3429%"
            },
            "scores": {
                "News_content": "健帆生物：占总股本0.3429%限售股将于5月7日上市流通 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]